NIAID HIV and Emerging Infectious Diseases Program

Healthy Volunteer Studies

Studies of healthy volunteers are crucial to the understanding and treatment of diseases. They provide a baseline for measuring the extent of disease and provide important information about the safety and effectiveness of various treatments.

There is no risk of contracting HIV/AIDS from any of these studies.

For questions about participating in any of these clinical studies, contact: Patient Recruitment and Public Liaison Office Toll Free: 1-800-411-1222 TTY: 1-866-411-1010 Se habla español. Office hours: 8 am to 8 pm, Eastern Time

Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test

(TST - Protocol #06-I-0030)

NIH is conducting a research study to investigate the human immune response to tuberculosis infection. Volunteers over 18 years old who have not been treated for tuberculosis are eligible to participate. The study involves up to 6 visits for placement of a tuberculin skin test and follow-up blood tests. The study is recruiting patients residing in the Washington, DC, Maryland, and Virginia metropolitan area. Volunteers will be compensated.

The Influence of Concurrent Administration of Echinacea purpurea, Ginkgo Biloba, or Panax Ginseng on the Steady State Pharmacokinetic Profile of Lopinavir/Ritonavir in Healthy Volunteers

(HERBPK - Protocol #05-CC-0082)

We are seeking male and female volunteers ages 18 – 50 years for a research study to determine whether the herbal supplements Echinacea purpurea, ginkgo biloba, and Panax ginseng change the body's reaction to the HIV protease inhibitor combination lopinavir/ritonavir. In order to participate, you must be in good health. Volunteers will be compensated.

For questions about participating in any of these clinical studies, contact: Patient Recruitment and Public Liaison Office Toll Free: 1-800-411-1222 TTY: 1-866-411-1010 Se habla español. Office hours: 8 am to 8 pm, Eastern Time

back to top